Press Release: bioLytical : bioLytical Announces Final Results of Substantial Issuer Bid

VANCOUVER, British Columbia, Aug. 23, 2024 (GLOBE NEWSWIRE) -- bioLytical Laboratories Inc. (the Company or bioLytical) announces that it has taken up and paid for 18,234,667 common shares (the Purchased Shares) at a price of CAD$0.15 per...